N
KMTS

Nuveen’s Kestra Medical Technologies KMTS Stock Holding History

Nuveen’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$635K Buy
31,877
+8,427
+36% +$199K ﹤0.01% 2753
2025
Q4 		$622K Buy
23,450
+6,291
+37% +$162K ﹤0.01% 2792
2025
Q3 		$408K Hold
17,159
– – ﹤0.01% 2971
2025
Q2 		$284K Buy
+17,159
New +$375K ﹤0.01% 3078

Other funds holding KMTS

BCI
Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AP
Andera Partners Paris $177M AUM
YF
Yu Fan $97M AUM 57.2% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Nuveen's KMTS Position: Q1 2026 in Review

Nuveen increased its Kestra Medical Technologies (KMTS) stake by 36% in Q1 2026, buying an estimated $199K and bringing the position to 31,877 shares worth $635K. The position accounts for ﹤0.01% of the portfolio, ranked #2753.

Nuveen first reported a position in KMTS in Q2 2025 and has held it in 4 quarters since. 103 funds tracked by Wall St. Rank hold KMTS as of Q1 2026.

  • Nuveen held 31,877 shares of Kestra Medical Technologies worth $635K as of Q1 2026.
  • Nuveen bought 8,427 Kestra Medical Technologies shares in Q1 2026, an estimated $199K.
  • Kestra Medical Technologies made up ﹤0.01% of Nuveen's portfolio in Q1 2026, its #2753 holding.
  • Nuveen first reported a position in Kestra Medical Technologies in Q2 2025 and has held it in 4 quarters since.
  • 103 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q1 2026.

Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.